Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Mount Rainier Acquisition Corp (RNER)

Mount Rainier Acquisition Corp (RNER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mount Rainier Acquisition Corp 256 WEST 38TH STREET 15TH FLOOR NEW YORK NY 10018 USA

https://www.rainieracquisitioncorp.com P: 212-785-4680

Description:

RainEarth Inc was incorporated in the State of Nevada on March 14, 2006 under the name of Gold Rock Resources Inc. On March 27, 2009, the Company changed its name to RainEarth Inc. It is a developing stage company and seeking new business opportunities. The Company would provide Advice and assistance relating to development of marketing and provision of consultancy services, particularly as related to the Business to China RainEarth. China RainEarth will retain the services of the Company in relation to the current and proposed operations of China RainEarth's business in the People's Republic of China. Competition among pharmaceutical and other companies that develop, manufacture or market pharmaceutical products, including blood dialysis, is intense. The Company competes with these entities in all areas of business, including competing to attract and retain qualified scientific and technical personnel. China RainEarth relies on trade secrets, unpatented proprietary know-how, continuing technological innovation and patent protection to preserve its competitive position.

Key Statistics

Overview:

Market Capitalization, $K 110,573
Enterprise Value, $K 110,573
Shares Outstanding, K 22,159
Annual Sales, $ 0 K
Annual Net Income, $ -1,491 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,051 K
% of Insider Shareholders 6.70%
% of Institutional Shareholders 66.74%
Float, K 20,674
% Float 93.30%
Short Volume Ratio 0.49

Growth:

1-Year Return -49.90%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm 0.00
EPS Growth vs. Prev Year 204.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

RNER Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.00
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar